SEC Form D · filed June 7, 2023
Lyndra Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (32)
Carlo G. Traverso · Watertown, MADirectorDoug S. Dachille · Watertown, MADirectorPatricia S. Hurter · Watertown, MAExec · DirectorHelene S. Madonick · Watertown, MADirectorCatherine S. Reynolds · Watertown, MADirectorZafi S. Avnur · Watertown, MADirectorRobert S. Langer · Watertown, MADirectorJessica G. Ballinger · Watertown, MAExecAmy Schulman · Watertown, MADirectorAshish S. Singh · Watertown, MADirectorJonathan Bombaci · Lowell, MADirectorTodd Wheatley · Lowell, MAExec · DirectorDestry Witt · Madison, WIDirectorJLL Exchange TRS, LLC · Chicago, ILDirectorMatthew Perimian · Lowell, MADirectorMatthew L. Gefter · Austin, TXDirectorBakhtear Talukdar · Madison, WIExecAdrienne Becker · New York, NYDirectorLaSalle Investment Management, Inc · Chicago, ILDirectorMichael H. Richardson · ST. HELIER, Y9DirectorJillian Moo-Young · Watertown, MADirectorAP GPE X GP Limited Partnership · Boston, MAExec · DirectorRichard Kane · Boston, MADirectorTimothy J. Ozanne · Bozeman, MTDirectorVikas L. Agrawal · ANN ARBOR, MIDirectorSergil R. Naviwala · Atlanta, GADirectorAnthony R. Tittanegro · Atlanta, GAExecPatrick R. Leardo · Atlanta, GADirectorPeter Mallouk · Overland Park, KSDirectorCarlyon J. Knight-Evans · Hong Kong, Hong KongDirectorChristopher P. Nash · Hong Kong, Hong KongDirectorJillian Moo-Young · Watertown, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗